Fidelity Select Pharmaceuticals Portfolio (FPHAX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
32.78
+0.11 (0.34%)
At close: Feb 13, 2026
FPHAX Holdings Information
FPHAX is a mutual fund with a total of 57 individual holdings. The top holdings are Eli Lilly and Company stock at 25.87%, AstraZeneca at 11.11%, Johnson & Johnson at 8.58%, Merck & Co. at 5.12%, and Roche Holding AG at 5.00%.
Total Holdings
57
Top 10 Percentage
76.85%
Asset Class
Equity
Fund Category
Health
Assets
1.43B
Forward PE Ratio
18.31
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 25.87% |
| 2 | AZN | AstraZeneca PLC | 11.11% |
| 3 | JNJ | Johnson & Johnson | 8.58% |
| 4 | MRK | Merck & Co., Inc. | 5.12% |
| 5 | SWX: ROG | Roche Holding AG | 5.00% |
| 6 | GSK | GSK plc | 4.89% |
| 7 | GILD | Gilead Sciences, Inc. | 4.88% |
| 8 | EBR: UCB | UCB SA | 4.82% |
| 9 | ELAN | Elanco Animal Health Incorporated | 4.29% |
| 10 | RPRX | Royalty Pharma plc | 2.29% |
| 11 | LEGN | Legend Biotech Corporation | 1.98% |
| 12 | EBR: TUB | Financière de Tubize SA | 1.66% |
| 13 | QURE | uniQure N.V. | 1.63% |
| 14 | MRNA | Moderna, Inc. | 1.41% |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 1.35% |
| 16 | OCUL | Ocular Therapeutix, Inc. | 1.20% |
| 17 | BIIB | Biogen Inc. | 1.05% |
| 18 | ETR: MRK | Merck KGaA | 1.00% |
| 19 | PTCT | PTC Therapeutics, Inc. | 0.97% |
| 20 | BNTX | BioNTech SE | 0.93% |
| 21 | XENE | Xenon Pharmaceuticals Inc. | 0.89% |
| 22 | MLYS | Mineralys Therapeutics, Inc. | 0.87% |
| 23 | CAPR | Capricor Therapeutics, Inc. | 0.83% |
| 24 | AXSM | Axsome Therapeutics, Inc. | 0.66% |
| 25 | BEAM | Beam Therapeutics Inc. | 0.65% |
As of Dec 31, 2025